Board of Directors
Mark Pavao, Chair
Managing Partner, Biotech Value Advisors
Mark Pavao has been a commercial leader in the global biopharma industry for 30+ years. Mark currently supports developing biotech companies with commercial and go-to-market strategy and tactical planning. Previous roles include President and CEO of R-Pharm US, President Bristol-Myers Squibb (BMS) / AstraZeneca Diabetes Alliance, President Emerging Markets Region at BMS, and SVP of Global Market Access and Pricing at BMS. Earlier, Mark held sales and marketing leadership roles at Bristol-Myers Squibb, SmithKline Beecham Pharmaceuticals, NitroMed Inc., and HeliosHealth. Mark has lived and/or worked in Brazil, Peru, Spain, Netherlands, Russia, India, China, Turkey, and the US. He received his MBA from Wharton and a BA from UNC-Chapel Hill, where he was a Morehead Scholar.
Senior Vice President, Global Corporate Affairs, Kellogg Company
Kris Bahner leads Communications, Philanthropy, Sustainability and Government for Kellogg Company. Kellogg is committed to creating Better Days for three billion people by the end of 2030 through Kellogg’s Better Days global purpose platform addressing the interconnected issues of health, food security and climate change. Kris was the architect of this award-winning platform. She is a member of Kellogg Company’s executive committee. She serves as the company’s lead corporate spokesperson and oversees the company’s annual global Corporate Responsibility report. Prior to joining Kellogg in 2006, Kris held a variety of corporate affairs roles with Kraft Foods. Previously, she led public relations programs for food industry clients at both Edelman Public Relations Worldwide and Powers Agency. She graduated magna cum laude with a Bachelor of Arts degree in communications and public relations from Miami University in Oxford, Ohio.
Co-Founder & Strategic Advisor, MiracleFeet
Chesca Colloredo-Mansfeld co-founded MiracleFeet in 2010. She helped to establish and then lead MiracleFeet as Executive Director and CEO until October 2022. During that time, organization grew to support 300+ clinics in over 30 countries, enrolling over 65,000 children in treatment, developed a low-cost brace and a sophisticated data collection and M&E system, both of which form critical elements of MiracleFeet’s replicable program model, and raised over $45M to support MiracleFeet’s global expansion. Chesca continues to support MiracleFeet as a Strategic Advisor focusing on major donors and high-level strategy. Her previous experience includes working for Boston Consulting Group, Goldman Sachs, internet start-ups eToys and CitySearch, Universities of Iowa and North Carolina business schools, and International Rescue Committee. Chesca is originally from England, grew up in Africa and Asia and spent time living and working in Pakistan and Ecuador. Chesca received an MBA from Stanford, where she was an Arjay Miller Scholar, and a BA in Economics and Political Science from UNC-Chapel Hill, where she was a Morehead-Cain Scholar. She and her husband, Rudi, have three children and live in Chapel Hill, NC.
Michelle Cooper became passionate about helping children around the world after her third child, Braden, was born with clubfoot and treated in the United States by Dr. Jose Morcende. She holds a graduate degree from Florida Atlantic University and an undergraduate degree from the University of Michigan. A former speech-language pathologist and designer handbag buyer, Michelle currently resides in Long Island, New York.
Hans Dekker, Secretary
President, Community Foundation of New Jersey
Hans Dekker has served as president of the Community Foundation of New Jersey since June 2003. During his tenure, the Foundation’s funds have dispersed over $280 million in grants to charitable causes. Hans is a past chair of the Council of New Jersey Grantmakers and a trustee of the Hyde and Watson Foundation and the Ohl Foundation. He has a background in both community foundation and community development work. Prior to his role at the Community Foundation of New Jersey, Hans served as the Executive Vice President of the Baton Rouge Area Foundation. He received his master’s degree in public policy from the University of California at Berkeley.
Åro Tilde Eide
Managing Director, Emilia GmbH
Åro Tilde Eide is a Managing Director of Emilia GmbH, a private wealth management company, and in addition is a member of MiracleFeet Germany’s Board of Directors. Åro has previously worked in market research for the Norwegian Trade Commission in New York, in strategic management planning in the oil industry for Esso Norge AS, and as Account Director in the Corporate Identity and Brand Building company Scandinavian Design Group and served as a Board Member of Stiftung Landheim Schondorf. Åro is a Norwegian citizen living in Munich with her husband Georg and their three children Beatrix, Ingerid, and Frederik, and holds a Bachelor of Business Degree from BI – Norwegian Business School and an MBA from INSEAD in France.
Founder, Eitel Global, LLC
Sue Eitel, BScPT, MAEd is a rehabilitation specialist and the founder of Eitel Global, LLC, a consultancy service for proposal writing, program assessments, and monitoring & evaluation — all related to international disability and rehabilitation programs. Her extensive background includes serving as Senior Rehabilitation Advisor with USAID, as Country Director in Angola and Ethiopia for Humanity & Inclusion, and as a physical therapist in Ethiopia, Romania, and Thailand. In addition, she has piloted a small grants disability program in Uganda through Pact, and created amputee support networks in six mine-affected countries for the Landmine Survivors Network. She served as a Peace Corps volunteer in Thailand and is a member of the American Physical Therapy Association.
Jarret Fass, Treasurer
Co-Founder and Managing Partner, Pierpoint Capital
Jarret Fass is an experienced entrepreneur, executive and investor. As a passionate business builder, Jarret co-founded family office backed Pierpoint Capital to invest in differentiated technology-related businesses and to selectively launch platform companies within the firm’s target industries. Jarret is the co-founder of Emanate Biomedical, a medical device company developing non-invasive therapies for oral diseases and two Israel-based medical technology companies developing novel therapies in the structural heart disease space. He also actively works with and serves on the board of several Pierpoint portfolio companies including Hospital IQ, an AI-enabled healthcare operations management platform and CoreFlow, a precision aeromechanical manufacturing equipment company. Jarret previously was a Principal at Selway Capital, a technology focused multi-stage private equity firm. He began his career as an Analyst in the Corporate Strategy Group at Bear Stearns. He holds a BA from Connecticut College and an MBA from Columbia Business School.
Joshua Hyman, MD, Medical Advisor
Professor of Orthopedic Surgery, Columbia University
Dr. Josh Hyman is Professor of Orthopedic Surgery at Columbia University, Attending Physician at New York-Presbyterian Hospital/Columbia University Medical Center, and Director of Pediatric Orthopedic Surgery. Dr. Hyman’s research focuses on methods of measuring quality of life in children. He is also actively involved in research trials on clubfoot, scoliosis and neuromuscular diseases in children. Josh completed his orthopedic surgical training at Harvard University and Massachusetts General Hospital.
Vice President, Programs, The End Fund
Carol Karutu previously served as Chief of Party for a USAID funded integrated health project implemented by IntraHealth International in Eastern Uganda. She is a 2014/2015 American Association of University Women (AAUW) International Fellow; a 2010 Boston University Distinguished Alumni Award recipient; a 2004 recipient of the Boston University Women’s Guild Award for Academic Excellence and a 2003 recipient of the PEO International Peace Scholarship. Carol received her Doctorate in Public Health and Master’s in Public Health from Boston University School of Public Health and a Bachelor of Science from Jomo Kenyatta University of Agriculture and Technology in Kenya.
Daphne de Souza Lima Sorensen
Chief Executive Officer (CEO), MiracleFeet
Daphne de Souza Lima Sorensen has 20 years’ experience in international development, social justice and child and human rights, leading teams across Latin America and Africa. She oversees global operations and staff, adding strategic leadership capacity to MiracleFeet’s growing team and impact. Daphne joined MiracleFeet from the Lumos Foundation, where she served as regional director for Latin America & Caribbean programs. For more than a decade prior, she held leadership roles at Save the Children—as country director in Bolivia and provincial program manager in Mozambique—and CARE as program coordinator in Brazil. She has also lived and worked in Uganda, Angola, Guatemala, Panama, and El Salvador. Daphne earned her master’s degree in Leadership from Duquesne University and bachelor’s in International Studies and Development and Economics from American University.
In addition to our current Board of Directors, we would also like to thank the following people who played important roles in creating and building MiracleFeet, many of whom also served as Board members:
Roger Berman (Co-Founder)
Bridget Ryan Berman (Co-Founder)
Jose Morcuende, M.D.
Sarita Narson Jairath
"I’ve watched MiracleFeet transform lives
…and it’s thrilling.”
Nicholas Kristof, The New York TimesGet Involved